- Home
- IBN vs BMY Comparison
IBN vs BMY Comparison
Compare IBN & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBN
- BMY
- Stock Information
- Founded
- IBN 1955
- BMY 1887
- Country
- IBN India
- BMY United States
- Employees
- IBN N/A
- BMY N/A
- Industry
- IBN Commercial Banks
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- IBN Finance
- BMY Health Care
- Exchange
- IBN Nasdaq
- BMY Nasdaq
- Market Cap
- IBN 108.1B
- BMY 120.5B
- IPO Year
- IBN 1999
- BMY N/A
- Fundamental
- Price
- IBN $31.26
- BMY $57.83
- Analyst Decision
- IBN
- BMY Hold
- Analyst Count
- IBN 0
- BMY 14
- Target Price
- IBN N/A
- BMY $58.00
- AVG Volume (30 Days)
- IBN 5.3M
- BMY 12.3M
- Earning Date
- IBN 04-28-2025
- BMY 04-24-2025
- Dividend Yield
- IBN 0.76%
- BMY 4.29%
- EPS Growth
- IBN 15.36
- BMY N/A
- EPS
- IBN 0.80
- BMY N/A
- Revenue
- IBN $20,510,222,156.00
- BMY $48,300,000,000.00
- Revenue This Year
- IBN N/A
- BMY N/A
- Revenue Next Year
- IBN $11.81
- BMY N/A
- P/E Ratio
- IBN $19.13
- BMY N/A
- Revenue Growth
- IBN 27.11
- BMY 7.32
- 52 Week Low
- IBN $25.13
- BMY $39.35
- 52 Week High
- IBN $32.14
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- IBN 65.48
- BMY 42.54
- Support Level
- IBN $30.98
- BMY $58.23
- Resistance Level
- IBN $31.74
- BMY $61.64
- Average True Range (ATR)
- IBN 0.37
- BMY 1.58
- MACD
- IBN 0.04
- BMY -0.28
- Stochastic Oscillator
- IBN 71.92
- BMY 4.27
About IBN ICICI Bank Limited
ICICI Bank Ltd provides banking services. The company's operating segments include Retail Banking; Wholesale Banking; Treasury, Life insurance, Other Banking Business, and Others. The company generates maximum revenue from the Retail Banking segment which includes exposures of the Bank, which satisfy the four qualifying criteria of a regulatory retail portfolio as stipulated by RBI guidelines on the Basel III framework as well as includes income from credit cards, debit cards, third party product distribution, and the associated costs. Geographical segments include Domestic operations and Foreign operations. The company generates the majority of its revenue from the domestic operations.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.